1.
J Palliat Med
; 20(9): 1042-1044, 2017 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28488910
RESUMO
Methadone use as a second-line agent for severe cancer-related pain is increasing in the field of hospice and palliative care. It has a number of qualities that make its use favorable, including lack of known active metabolites and presumed relative safety from adverse effects such as opioid-induced neurotoxicity (OIN). This article describes a case of a patient undergoing treatment of severe cancer-related pain who developed OIN in the setting of oral methadone use. As the use of methadone increases, more research into its pharmacologic and pharmacokinetic properties will be necessary.
Assuntos
Analgésicos Opioides/administração & dosagem , Analgésicos Opioides/efeitos adversos , Metadona/administração & dosagem , Metadona/efeitos adversos , Neoplasias/patologia , Síndromes Neurotóxicas/etiologia , Dor/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias/tratamento farmacológico , Cuidados Paliativos
2.
J Trauma
; 68(3): 746, 2010 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20220429